Monthly Archives: November 2020
UPDATE: CDC issues updated guidance for Thanksgiving holiday travel
On Nov. 19, the Centers for Disease Control and Prevention updated its guidance for Thanksgiving holiday travel. The revised guidance encourages staying home as the best means to protect yourself and others. Continue reading
NEW: Why does COVID-19 seem to spare children?
Researchers at Vanderbilt University Medical Center and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children. Continue reading
NEW: Why does COVID-19 seem to spare children?
Researchers at Vanderbilt University Medical Center and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children. Continue reading
UPDATE: COVID exposure/post-infection and return-to-work FAQs
Exposure is defined as being within 6 feet of an infected person for a cumulative total of 15 minutes or more over a 24-hour period. Continue reading
NEW: Message from Dr. C. Wright Pinson: VUMC called on to rise to the challenge as COVID cases surge
Colleagues, All indications are that we will be heading into a strengthening storm following the Thanksgiving holiday. Tennessee’s COVID metrics are getting worse as the U.S. is now approaching 200,000 new cases each day. Tragically, more than 255,000 … Continue reading
Fusobacterium nucleatum adheres to Clostridioides difficile via the RadD adhesin to enhance biofilm formation in intestinal mucus
Although Clostridioides difficile infection (CDI) is known to involve the disruption of the gut microbiota, little is understood regarding how mucus-associated microbes interact with C. difficile. We hypothesized that select mucus-associated bacteria w… Continue reading
Colorectal cancer screening with repeated fecal immunochemical test versus sigmoidoscopy: baseline results from a randomized trial
The comparative effectiveness of sigmoidoscopy and fecal immunochemical testing (FIT) for colorectal cancer (CRC) screening is unknown. Continue reading
Pregnancy and Neonatal Outcomes after Fetal Exposure To Biologics and Thiopurines among Women with Inflammatory Bowel Disease
Pregnant women with inflammatory bowel disease (IBD) may require biologic or thiopurine therapy to control disease activity. Lack of safety data has led to therapy discontinuation during pregnancy with health repercussions to mother and child. Continue reading